LITS - MEI Pharma, Inc.
1.18
0 0%
Share volume: 397,835
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.18
0.00
0.00%
View ratios
| Fiscal Date | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 11-09-2023 | 02-13-2024 | 05-09-2024 | 11-12-2024 | 11-12-2024 | 02-12-2025 | 05-13-2025 | 09-26-2025 | |
| Assets | |||||||||
| Total Assets | 101.251 M | 78.538 M | 71.260 M | 41.375 M | 27.750 M | 24.385 M | 20.779 M | 18.285 M | |
| Current Assets | 88.422 M | 66.172 M | 59.366 M | 40.769 M | 27.745 M | 24.385 M | 20.779 M | 18.285 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 6.220 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 6.220 M | 54.306 M | 54.184 M | 34.640 M | 19.953 M | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 82.202 M | 5.174 M | 2.368 M | 3.705 M | 6.952 M | 23.739 M | 20.472 M | 18.011 M | |
| Total Non-current Assets | 12.829 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.229 M | 1.144 M | 1.058 M | 392.000 K | 5.000 K | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 11.222 M | 10.836 M | 214.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 101.251 M | 78.538 M | 71.260 M | 41.375 M | 27.750 M | 24.385 M | 20.779 M | 18.285 M | |
| Total liabilities | 19.890 M | 19.050 M | 20.231 M | 8.355 M | 2.872 M | 2.287 M | 1.238 M | 1.354 M | |
| Total current liabilities | 8.564 M | 8.038 M | 9.616 M | 8.355 M | 2.872 M | 2.287 M | 1.238 M | 1.354 M | |
| Accounts Payable | 3.220 M | 1.378 M | 3.176 M | 3.168 M | 976.000 K | 596.000 K | 177.000 K | 176.000 K | |
| Other liabilities | 0.000 | 11.012 M | 10.615 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 11.012 M | 10.615 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 81.361 M | 59.488 M | 51.029 M | 33.020 M | 24.878 M | 22.098 M | 19.541 M | 16.931 M | |
| Common stock | 6.663 M | 420.174 M | 420.842 M | 421.239 M | 421.104 M | 421.001 M | 421.017 M | 421.095 M | |
| Retained earnings | -349.623 M | -360.686 M | -369.813 M | -388.219 M | -396.226 M | -398.903 M | -401.476 M | -404.164 M |